Autopsy report · NCT02468778
SHIELD II Clinical Investigation
Cause of deathFunding or business
“Abbott has decided to discontinue our percutaneous heart pump (PHP) program and the SHIELD II trial because the product was not meeting the needs of the patients it was intended to serve.”
Life of this trial
- Registered 3 months before it started.
- Ran for about 5 years 9 months before it stopped.
- 54 participants enrolled.
- Results were posted on the registry 1 year 1 month after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Abbott Medical Devices
- Sponsor type
- Industry
- Conditions
- Coronary Artery Disease
- Interventions
- HeartMate PHP; Any Abiomed Impella® device approved for use in high-risk PCI
- Participants
- 54
- Sites
- 58
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.